About
Prenostics develops a blood test technology for detecting cancer at the earliest stages (stage 0-2), enabling earlier diagnosis and intervention particularly for ovarian cancer and lung nodules.
Explore Prenostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.